ANEUVO is a platform and therapy development company focused on treating disabling diseases and conditions that have not been curable through traditional pharmaceutical approaches.
The ANEUVO ExaStim® Stimulation System is a non-invasive neuromodulation system which has received CE Mark approval and FDA Breakthrough Device Designation for treating spinal cord injury.
ExaStim® is only cleared for use in Europe and is not commercially available in other geographies. ExaStim® is limited by United States law to investigational use.
Company Details
- Employees
- 19
- Address
- Los Angeles, Us
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://aneuvo.com
- Keywords
- neuromodulation, spinal cord injury, neuro rehabilitation, neurostimulation, medtech, paralysis, neurostim, physiotherapy, sci, biotech.
- HQ
- Los Angeles
Aneuvo Questions
Aneuvo's website is https://aneuvo.com
Aneuvo's LinkedIn profile is https://www.linkedin.com/company/aneuvo
Aneuvo has
19 employees.
View email and phone details for 19
employees at Aneuvo.
Aneuvo's industry is
Medical Equipment Manufacturing
Aneuvo's top competitors are
Precision Neuroscience,
Neurosigma,
Spinex Inc.,
Onward Medical,
Synergia Medical,
Axonics, Inc.,
Revision Implant,
Motif Neurotech,
Neuropace,
Neuralace Medical®.
Aneuvo's categories are Medical Equipment Manufacturing
